InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Morosini Deborah, Directeur Exécutif des Affaires Cliniques. Insider active across 1 companies, notably Prelude Therapeutics Inc. In total, 4 filings have been recorded. The latest transaction was filed on 15 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€5,0623,016 shares@ €1.67830.0014% mcap1.5% of flow
Common Stock
SEC:0001209191-21-070352·
€5,0623,016 shares@ €1.67830.0014% mcap0.8% of flow
Common Stock
SEC:0001209191-21-070352:0·
€325,03528,751 shares@ €11.30520.091% mcap98.5% of flow
Common Stock
SEC:0001209191-21-065616·
€325,03528,751 shares@ €11.30520.091% mcap49.2% of flow
Common Stock
SEC:0001209191-21-065616:0·
4 of 4 declarations
About Morosini Deborah
Deborah Morosini is the Executive Vice President of Clinical Affairs at Prelude Therapeutics Inc. She oversees the company's clinical initiatives, contributing to innovation and healthcare improvement.
